MetLife Investment Management, LLC - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 75 filers reported holding RELMADA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$521,649
+94.9%
14,0910.0%0.00%
+100.0%
Q2 2022$267,588
-29.6%
14,0910.0%0.00%
-33.3%
Q1 2022$380,316
+149.9%
14,091
+108.6%
0.00%
+200.0%
Q4 2021$152,168
-14.0%
6,7540.0%0.00%
-50.0%
Q3 2021$177,022
-18.1%
6,7540.0%0.00%0.0%
Q2 2021$216,196
-9.1%
6,7540.0%0.00%0.0%
Q1 2021$237,808
+9.8%
6,7540.0%0.00%0.0%
Q4 2020$216,601
-14.8%
6,7540.0%0.00%
-33.3%
Q3 2020$254,085
-15.9%
6,7540.0%0.00%0.0%
Q2 2020$302,2426,7540.00%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Guild Investment Management, Inc. 111,550$274,4130.39%
Deep Track Capital, LP 2,837,818$6,981,0320.32%
apricus wealth, LLC 77,329$219,6140.19%
PARSONS CAPITAL MANAGEMENT INC/RI 873,312$2,148,3480.16%
Palo Alto Investors LP 732,400$1,801,7040.15%
RTW INVESTMENTS, LP 2,131,835$5,244,3140.10%
AdvisorShares Investments LLC 112,898$277,7290.08%
GSA CAPITAL PARTNERS LLP 271,524$6680.07%
Spotlight Asset Group, Inc. 20,000$49,2000.04%
Savior LLC 3,500$8,6100.04%
View complete list of RELMADA THERAPEUTICS INC shareholders